Search Results - "Almer, S"

Mercaptopurine treatment should be considered in azathioprine intolerant patients with inflammatory bowel disease by HINDORF, U., JOHANSSON, M., ERIKSSON, A., KVIFORS, E., ALMER, S. H. C.

“…Summary Background  Adverse drug reactions are a significant reason for therapeutic failure during thiopurine treatment of inflammatory bowel disease. Some…”
Get full text

The epidemiology and clinical features of portal vein thrombosis: a multicentre study by Rajani, R., Björnsson, E., Bergquist, A., Danielsson, Å., Gustavsson, A., Grip, O., Melin, T., Sangfelt, P., Wallerstedt, S., Almer, S.

“…Aliment Pharmacol Ther 2010; 32: 1154–1162 Summary Background  Reliable epidemiological data for portal vein thrombosis are lacking. Aims  To investigate the…”
Get full text

Vitamin D downregulates the IL-23 receptor pathway in human mucosal group 3 innate lymphoid cells by Konya, Viktoria, PhD, Czarnewski, Paulo, PhD, Forkel, Marianne, MSc, Rao, Anna, PhD, Kokkinou, Efthymia, MSc, Villablanca, Eduardo J., PhD, Almer, Sven, MD, PhD, Lindforss, Ulrik, MD, PhD, Friberg, Danielle, MD, PhD, Höög, Charlotte, MD, Bergman, Peter, MD, PhD, Mjösberg, Jenny, PhD

“…Background Vitamin D deficiency is a risk factor for inflammatory bowel disease (IBD). The IL-23–driven tissue-resident group 3 innate lymphoid cells (ILC3s)…”
Get full text

Acute liver failure in Sweden: etiology and outcome by Wei, G., Bergquist, A., Broomé, U., Lindgren, S., Wallerstedt, S., Almer, S., Sangfelt, P., Danielsson, Å., Sandberg‐Gertzén, H., Lööf, L., Prytz, H., Björnsson, E.

“… Objective.  To determine the causes and outcome of all patients with acute liver failure (ALF) in Sweden 1994–2003 and study the diagnostic accuracy of…”
Get full text

Adverse events leading to modification of therapy in a large cohort of patients with inflammatory bowel disease by HINDORF, U., LINDQVIST, M., HILDEBRAND, H., FAGERBERG, U., ALMER, S.

“…Summary Background Adverse events leading to discontinuation or dose reduction of thiopurine therapy occur in 9–28% of patients with inflammatory bowel…”
Get full text

Infliximab as rescue therapy in hospitalised patients with steroid‐refractory acute ulcerative colitis: a long‐term follow‐up of 211 Swedish patients by Sjöberg, M., Magnuson, A., Björk, J., Benoni, C., Almer, S., Friis‐Liby, I., Hertervig, E., Olsson, M., Karlén, P., Eriksson, A., Midhagen, G., Carlson, M., Lapidus, A., Halfvarson, J., Tysk, C.

“…Summary Background Rescue therapy with infliximab (IFX) has been proven effective in a steroid‐refractory attack of ulcerative colitis (UC). The long‐term…”
Get full text

Long‐term outcome of infliximab treatment in chronic active ulcerative colitis: a Swedish multicentre study of 250 patients by Angelison, L., Almer, S., Eriksson, A., Karling, P., Fagerberg, U., Halfvarson, J., Thörn, M., Björk, J., Hindorf, U., Löfberg, R., Bajor, A., Hjortswang, H., Hammarlund, P., Grip, O., Torp, J., Marsal, J., Hertervig, E.

“…Summary Background Real‐life long‐term data on infliximab treatment in ulcerative colitis are limited. Aim To study the long‐term efficacy and safety of…”
Get full text

Pharmacogenetics during standardised initiation of thiopurine treatment in inflammatory bowel disease by Hindorf, U, Lindqvist, M, Peterson, C, Söderkvist, P, Ström, M, Hjortswang, H, Pousette, A, Almer, S

“…Background: Firm recommendations about the way thiopurine drugs are introduced and the use of thiopurine methyltransferase (TPMT) and metabolite measurements…”
Get full text

Use of complementary and alternative medicine in Swedish patients with inflammatory bowel disease: a controlled study by Oxelmark, Lena, Lindberg, Annelie, Löfberg, Robert, Sternby, Berit, Eriksson, Anders, Almer, Sven, Befrits, Ragnar, Fossum, Bjöörn, Karlén, Per, Broström, Olle, Tysk, Curt

“…BACKGROUNDThere is an increasing interest in complementary and alternative medicine (CAM) in patients with chronic diseases, including those with inflammatory…”
Get full text

Letter: successful mercaptopurine therapy after azathioprine‐related pancreatitis in patients with IBD – authors' reply by Hindorf, U., Almer, S.

Get full text

A novel serum protein signature as biomarker for Inflammatory Bowel Disease: A diagnostic performance and prediction modelling study using data from two independent inception cohorts by Bazov, Igor, Kruse, Robert, Bergemalm, Daniel, Eriksson, Carl, Hedin, C. R., Carlson, M., van Nieuwenhoven, Michiel, Keita, Å. V., Magnusson, M. K., Almer, S., Strid, H., Mathisen, C. Bache-Wiig, Bengtsson, M. B., Aabrekk, T. Bergene, Medhus, A. W., Detlie, T. E., Frigstad, S. O., Huppertz-Hauss, G., Opheim, R., Ricanek, P., Kristensen, V. A., Salihovic, Samira, D'Amato, M., Öhman, L., Söderholm, J. D., Lindqvist, C. M., Repsilber, Dirk, Høivik, M. L., Halfvarson, Jonas

Get full text

Environmental factors in a population-based inception cohort of inflammatory bowel disease patients in Europe — An ECCO-EpiCom study by Burisch, J., Pedersen, N., Cukovic-Cavka, S., Turk, N., Kaimakliotis, I., Duricova, D., Bortlik, M., Shonová, O., Vind, I., Avnstrøm, S., Thorsgaard, N., Krabbe, S., Andersen, V., Dahlerup, J.F., Kjeldsen, J., Salupere, R., Olsen, J., Nielsen, K.R., Manninen, P., Collin, P., Katsanos, K.H., Tsianos, E.V., Ladefoged, K., Lakatos, L., Ragnarsson, G., Björnsson, E., Bailey, Y., O'Morain, C., Schwartz, D., Odes, S., Giannotta, M., Girardin, G., Kiudelis, G., Kupcinskas, L., Turcan, S., Barros, L., Magro, F., Lazar, D., Goldis, A., Nikulina, I., Belousova, E., Martinez-Ares, D., Hernandez, V., Almer, S., Zhulina, Y., Halfvarson, J., Arebi, N., Tsai, H.H., Sebastian, S., Lakatos, P.L., Langholz, E., Munkholm, P.

“…The incidence of inflammatory bowel disease (IBD) is increasing in Eastern Europe possibly due to changes in environmental factors towards a more “westernised”…”
Get full text

Health-related quality of life improves during one year of medical and surgical treatment in a European population-based inception cohort of patients with Inflammatory Bowel Disease — An ECCO-EpiCom study by Burisch, J., Weimers, P., Pedersen, N., Cukovic-Cavka, S., Vucelic, B., Kaimakliotis, I., Duricova, D., Bortlik, M., Shonová, O., Vind, I., Avnstrøm, S., Thorsgaard, N., Krabbe, S., Andersen, V., Dahlerup, J.F., Kjeldsen, J., Salupere, R., Olsen, J., Nielsen, K.R., Manninen, P., Collin, P., Katsanos, K.H., Tsianos, E.V., Ladefoged, K., Lakatos, L., Ragnarsson, G., Björnsson, E., Bailey, Y., O'Morain, C., Schwartz, D., Odes, S., Valpiani, D., Boni, M.C., Jonaitis, L., Kupcinskas, L., Turcan, S., Barros, L., Magro, F., Lazar, D., Goldis, A., Nikulina, I., Belousova, E., Fernandez, A., Sanroman, L., Almer, S., Zhulina, Y., Halfvarson, J., Arebi, N., Diggory, T., Sebastian, S., Lakatos, P.L., Langholz, E., Munkholm, P.

“…Health-related quality of life (HRQoL) is impaired in patients with Inflammatory Bowel Disease (IBD). The aim was prospectively to assess and validate the…”
Get full text

In Vitro Antibacterial Potency and Spectrum of ABT-492, a New Fluoroquinolone by Nilius, Angela M, Shen, Linus L, Hensey-Rudloff, Dena, Almer, Laurel S, Beyer, Jill M, Balli, Darlene J, Cai, Yingna, Flamm, Robert K

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Incidence and prevalence rates in Budd-Chiari syndrome by Rajani, R, Almer, S

Get more information

Dynamic Phasor Analysis of Periodic Systems by Almer, S., Jonsson, U.

“…The paper considers stability analysis of linear time-periodic (LTP) systems based on the dynamic phasor model (DPM). The DPM exploits the periodicity of the…”
Get full text

TNFSF15 Polymorphisms Are Associated With Susceptibility to Inflammatory Bowel Disease in a New European Cohort by THIEBAUT, R, KOTTI, S, BINDER, V, FINKEL, Y, PASCOE, L, HUGOT, J.-P, JUNG, C, MERLIN, F, COLOMBEL, J. F, LEMANN, M, ALMER, S, TYSK, C, O'MORAIN, M, GASSULL, M

“…Inflammatory bowel disease (IBD), e.g., Crohn's disease (CD) and ulcerative colitis (UC), is a complex genetic disorder. Tumor necrosis factor (ligand)…”
Get full text

Novel Strategies in the Thiopurine Treatment of Inflammatory Bowel Disease by Almer, S.

“…Thiopurine drugs are widely used as immunomodulatory and corticosteroid-sparing agents in inflammatory bowel disease. Despite being old drugs, a renewed…”
Get full text

927 RISK FOR HEPATOCELLULAR CARCINOMA IN AUTOIMMUNE HEPATITIS – IS THERE AN INDICATION FOR SURVEILLANCE? by Danielsson Borssén, Å, Lindgren, S, Bergquist, A, Almer, S, Sangfelt, P, Werner, M

Get full text

In Vitro and Bactericidal Activities of ABT-492, a Novel Fluoroquinolone, against Gram-Positive and Gram-Negative Organisms by ALMER, Laurel S, HOFFRAGE, Jennifer B, KELLER, Erika L, FLAMM, Robert K, SHORTRIDGE, Virginia D

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text